12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

  • bluebird bio BLUE shares rose 53.4% to $6.12 during Friday's after-market session. Trading volume for this security closed at 5.0 million, accounting for 206.3% of its average full-day volume over the last 100 days. The company's market cap stands at $437.2 million.
  • Aileron Therapeutics ALRN stock moved upwards by 27.46% to $0.53. The company's market cap stands at $48.1 million.
  • ABVC BioPharma ABVC shares moved upwards by 20.0% to $1.08. The company's market cap stands at $34.8 million.
  • Lixte Biotech Hldgs LIXT shares increased by 10.22% to $0.83. The market value of their outstanding shares is at $13.8 million.
  • Minerva Neurosciences NERV stock rose 8.2% to $0.43. The company's market cap stands at $18.3 million.
  • Oncternal Therapeutics ONCT shares moved upwards by 7.31% to $1.32. The company's market cap stands at $65.2 million.

Losers

  • Alpha Tau Medical DRTS stock decreased by 15.1% to $8.2 during Friday's after-market session. The company's market cap stands at $561.5 million.
  • Elevation Oncology ELEV stock decreased by 11.96% to $1.62. The market value of their outstanding shares is at $37.6 million.
  • Acurx Pharmaceuticals ACXP shares fell 7.43% to $3.49. The market value of their outstanding shares is at $35.8 million.
  • Stealth BioTherapeutics MITO shares fell 7.15% to $0.26. The market value of their outstanding shares is at $19.1 million.
  • ViewRay VRAY shares declined by 6.82% to $2.6. The company's market cap stands at $469.1 million.
  • Zosano Pharma ZSAN shares fell 6.75% to $0.52. The market value of their outstanding shares is at $2.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!